Skip to content

Author

Byeong-Keuk Kim

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Statin-Ezetimibe Combination Therapy versus Statin Monotherapy in Atherosclerotic Cardiovascular Disease: A Prespecified Secondary Analysis of the Randomized Ez-PAVE Trial.

BACKGROUND In a target-directed low-density lipoprotein cholesterol (LDL-C)-lowering strategy, the impact of the initial treatment regimen has not been investigated in patients with atherosclerotic cardiovascular disease. We compared the efficacy and safety of initial statin-ezetimibe combination therapy versus statin...

Sang-Hyup Lee, Y. Byun, Jin Won Kim et al. · 0 citations
Open access Aug 2026

Mid-Term Outcomes of Endovascular Aneurysm Repair With the INCRAFT Stent Graft System: Retrospective Combined Korean Multi-Center and Single-Center Registry Analysis.

In Korean patients with AAA, the INCRAFT stent-graft system demonstrated favorable mid-term outcomes, with low rates of aneurysm-related mortality, acceptable reintervention rates, and stable aneurysm sac behavior.

I. Jin, Young-Guk Ko, Seung-Jun Lee et al. · 0 citations
Open access Oct 2026

Telmisartan-Chlorthalidone Fixed-Dose Combination at Two Chlorthalidone Dose Levels versus Telmisartan in Uncontrolled Hypertension: A Phase III Trial.

BACKGROUND Evidence comparing different diuretic doses within fixed-dose combinations (FDCs) remains limited. We evaluated telmisartan/chlorthalidone FDCs according to chlorthalidone dose in patients with blood pressure (BP) inadequately controlled on telmisartan monotherapy. METHODS In this randomized, double-blind...

Seung-Whan Lee, Jin-Man Cho, SoonJun Hong et al. · 0 citations
Aug 2026

Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients.

Among patients at high risk for ischemic events 12 months after drug-eluting stent implantation, clopidogrel monotherapy was noninferior to extended DAPT with respect to net adverse clinical events at 24 months.

Seung-Jun Lee, Yong-Joon Lee, Kyounghoon Lee et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.